ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

 

Scientific Session 7: Treatment-free Remission
12:56

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Molecular Milestones Using the BCR-ABL1 qPCR Level and Doubling Time After Imatinib Discontinuation to Predict Successful Treatment-free Remission: Treatment-free Remission Accomplished by Dasatinib (TRAD) Trial

FEATURING Dennis Kim
  • 7 views
  • November 23, 2018
18:28

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

What Prevents the Disease from Relapsing after TKI Discontinuation

FEATURING Satu Mustjoki
  • 8 views
  • December 3, 2018
11:10

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Treatment-free Remission in Patients with Chronic Phase Chronic Myeloid Leukemia and Stable Deep Molecular Response Discontinuing Dasatinib (DASFREE)

FEATURING Susanne Saussele
  • 21 views
  • January 2, 2019